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Summary
Objective: Myositis ossificans is a rare non-neoplastic form
of heterotopic ossification most commonly described after
trauma or surgery, in the diabetic foot.
Design: We provide a review of the literature including
three illustrative cases.
Participants: Individuals presenting to the foot clinic.
Setting: Single centre, tertiary multidisciplinary specialist
diabetes foot clinic.
Results: We review the literature surrounding Myositis
ossificans, and describe three cases of Myositis ossificans
following foot surgery in people with diabetes. All of the
imaging was consistent with the descriptions of Myositis
ossificans reported elsewhere in large muscle groups.
These are the first reports of Myositis ossificans occurring
in the feet of people with diabetes.
Conclusions: Myositis ossificans has only very rarely been
described in the foot and, as far as we are aware, never in
people with diabetes. Given that the prevalence of diabetes
is increasing, and the foot problems requiring surgery are
also rising, we suggest that clinicians should be more aware
of this condition because it may occur more frequently.
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Introduction
We report the first cases (to our knowledge) of myo-
sitis ossificans in the ‘diabetic foot’.
Cases
Case 1
A 54-year-old lady, with a 20-year history of type 1
diabetes mellitus was admitted to our unit with
apparent osteomyelitis of her right first metatarsal
phalangeal joint. Two weeks prior she had been trea-
ted at a local unit with intravenous antibiotics and
surgical debridement. She had previously undergone
right foot first and second toe amputations, nine and
seven years previously, respectively. At presentation
to our specialist multidisciplinary foot clinic, her foot
was slightly swollen, but there were no other clinical
indicators of osteomyelitis. Radiographs of the foot
showed exuberant new bone formation adjacent to
the hallux metatarsal, reported as being ‘in keeping
with osteomyelitis’ (Figure 1(a)). An magnetic reso-
nance imaging scan of her foot was performed to
determine the presence and extent of any ongoing
bone infection. This showed a soft tissue mass on
the plantar and medial aspect of the first metatarsal,
corresponding to the area of ossification on the plain
radiograph. This was isointense to muscle on T1-
weighted sequences and slightly hyperintense on T2-
weighted sequences (Figure 1(b)). This was reported
as being ‘in keeping with heterotopic ossification and
Myositis ossificans’.
On the basis of the clinical appearance of the foot
and the radiological imaging a management plan was
formulated. This meant that patient was initially
fitted with specialist insoles for her shoes and sched-
uled to have an isotope bone scan 12 months later to
assess for the ongoing bony activity in her foot. If it
had stabilised she would be reviewed for consider-
ation for further surgery and removal of the hetero-
topic calcification.
Case 2
A 53-year-old man with a 13-year history of Type 2
diabetes mellitus presented to our foot clinic with an
ulcer over the plantar aspect of his right second meta-
tarsophalangeal joint and right dorsal second toe. He
was known to have a Charcot (neuroarthropathic)
foot on the left, diagnosed four years previously.
Three months prior to presentation, he had under-
gone a third metatarsal ray amputation for ulceration
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and osteomyelitis. On examination, the wound
appeared clean and a small piece of bone was
removed. Radiographs of the foot showed new bone
destruction centred on the neck of the second meta-
tarsal with dislocation of the second metatarsopha-
langeal joint, in keeping with osteomyelitis (Figure
2(a)). In accordance with our local antibiotic proto-
col, he was started on a course of oral co-amoxiclav.1
Despite this, an magnetic resonance imaging scan
done three weeks later showed extensive osteomyelitis
within the second metatarsal with bone fragmenta-
tion of the metatarsal head and involvement of the
metatarsophalangeal joint. In addition, there was
extensive periosseous phlegmon formation around
the second metatarsal shaft (Figure 2(b)). Despite
these radiological findings, the patient was reluctant
to pursue surgical options, opting for another course
of broad spectrum antibiotics. Another magnetic
resonance imaging scan performed 6 weeks later
showed persisting osteomyelitis involving the second
metatarsal, with an increasing larger concentric soft
tissue mass along the shaft of the second metatarsal
associated with bony destruction. However, clinically
his foot had no swelling or erythema. Over the sub-
sequent two months he had ongoing debridement and
offloading of his foot ulcer. Sequential radiographs
showed ongoing exuberant bone formation, bony
erosion and periosteal reaction of the right second
metatarsal (Figure 2(c)). His ulcer persisted and a
further magnetic resonance imaging scan suggested
ongoing osteomyelitis in the second metatarsal.
Nevertheless, on examination, his foot showed no evi-
dence suggestive of underlying infection. After discus-
sion with the specialist soft tissue radiologist, it was
felt that the images of the second metatarsal repre-
sented Myositis ossificans with concurrent
osteomyelitis.
Case 3
A 43-year-old man with a 12-year history of type 1
diabetes mellitus was referred to the foot team follow-
ing emergency amputation of his ischaemic and
infected left first toe. He was left with a large post-
operative wound site which was managed with
debridement and broad-spectrum antibiotics.
Radiographs of the foot initially showed healthy
callus formation, with a radiograph taken four
months later showing a new ossification centre at
the site of the stump, with remodelling of the residual
Figure 1. (a) Radiograph of the right foot of Case 1 showing exuberant new bone formation adjacent to the hallux metatarsal
and previous first and second toe amputations and (b) T2-weighted sequence magnetic resonance imaging right foot of Case 1
showing a soft tissue mass on the plantar and medial aspect of the first metatarsal.
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proximal phalanx of the first toe (Figure 3(a)).
Unfortunately, radiographs taken two months later
showed lucency in the soft tissue overlying the distal
stump and new distal bone resorption. A subsequent
magnetic resonance imaging verified the radiograph
findings, showing a subcutaneous sinus at the ampu-
tation site with diffuse periosseous soft tissue swel-
ling and low grade enhancement in keeping with
osteomyelitis. He underwent revision surgery and
further amputation at the metatarsophalangeal
joint of the first toe. Over the next four months,
the wound healed well, but the foot continued to
appear swollen. Sequential radiographs and
Magnetic resonance imaging of the foot showed
new callous formation and periosseous soft tissue
swelling at the first metatarsal, with new erosions
at the medial aspect and a periosteal reaction at
the lateral aspect (Figure 3(b)). More proximally,
soft tissue oedema appeared to extend concentrically
around the first and second metatarsal shafts, sug-
gesting persistent osteomyelitis. In contrast, clinical
examination and blood results indicated no evidence
of inflammation or infection. Despite these, and fur-
ther Magnetic resonance imaging suggesting reso-
lution of infection, his swelling persisted. Because
of this discrepancy, all of his imaging was again
reviewed by the multidisciplinary foot team and
the specialist radiologist. It was concluded that the
callous formation at the first amputation site and the
periosteal reaction at the lateral aspect of the meta-
tarsal head most likely represented Myositis ossifi-
cans, with concurrent osteomyelitis.
Discussion
Myositis ossificans is a rare non-neoplastic form of
heterotopic ossification. Myositis ossificans is an
ossifying lesion most commonly described as arising
in the large muscle groups of the upper and lower
limb, particularly those surrounding bone.2 The clin-
ical presentation of Myositis ossificans is variable, but
usually includes a history of repetitive minor trauma
or a specific injury leading to a haematoma.2–6
Nevertheless, often no causative reason can be iden-
tified. The incidence is approximately 2% in people
undergoing hip surgery and 20% in individuals inves-
tigated for thigh contusions.6 However, there are very
few cases of Myositis ossificans described in the foot,
and none occurring in people with diabetes or asso-
ciated with osteomyelitis.7
Different forms of Myositis ossificans have been
described. A classification coined by Noble in 1924
includes: (1) Fibrodysplasia ossificans progressiva, a
rare disease of childhood progressively involving all
skeletal muscles; (2) traumatic Myositis ossificans
which may follow acute or chronic trauma and
accounting for 80% of cases described and (3) non-
traumatic Myositis ossificans accounting for 20% of
cases described and usually associated with paraple-
gia, clotting disorders or chronic infection. In the lit-
erature, Myositis ossificans and heterotropic
ossification are often used interchangeably.5 In this
case series, we will be focusing on traumatic
Myositis ossificans, also known as Myositis ossificans
traumatica.
Figure 2. (a) Radiograph of the right foot of Case 2 showing new bone destruction centred on the neck of the second metatarsal
with dislocation of the second metatarsophalangeal joint, in keeping with osteomyelitis, (b) Magnetic resonance imaging of the right
foot of Case 2 showing extensive osteomyelitis within the second metatarsal with bone fragmentation of the metatarsal head and
involvement of the metatarsophalangeal joint, as well as extensive periosseous inflammatory phlegmon formation around the
second metatarsal shaft and (c) radiograph of the right foot of Case 2 showing ongoing exuberant bone formation, bony erosion
and periosteal reaction of the right second metatarsal.
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We present an illustrative case series of pedal
Myositis ossificans in three individuals with pre-exist-
ing diabetes related foot disease. All subjects gave
written consent. We suggest that this rare condition
may be frequently overlooked in people with diabetes
and may occur more frequently as the prevalence of
diabetes related foot disease increases.
Myositis ossificans typically forms after single or
repeated injury to soft tissue structures surrounding
bone.2,5 The pathogenesis is poorly understood, but
resultant necrosis or haematoma from these injuries is
considered the starting point for the inappropriate,
over-exuberant cellular response.4,6
Histology
Histologically, Myositis ossificans follows a charac-
teristic pattern of development with the formation
of distinct zonal layers.2,5,8 It forms in a chrono-
logical process which reflects various stages of cellular
maturation. Initially there is a central proliferating
mass made up of immature fibroblastic cells mixed
with inflammatory cells.2,3,5 Progressing outwards to
the intermediate and outer zones the cells become
more condensed and calcified, eventually becoming
mature bone. These characteristic layers form grad-
ually and can be appreciated after about three weeks.5
This is clinically relevant because the imaging of these
lesions is time dependant. Plain radiographic images
may not pick up the lesion early on in their develop-
ment and they will not be able to demonstrate the
zonal pathology described.2,3
Given the rarity of Myositis ossificans there may
be diagnostic uncertainty, with differentials including
neoplastic bone tumours, other non-neoplastic
tumour with bone formation and osteomyelitis.2
Clinically, the condition normally presents as a
tender erythematous growth with a gelatinous texture
which hardens and becomes well defined over weeks,
as it progressively forms into mature lamellar bone.2
Figure 3. (a) Radiograph of the left foot of Case 3 showing new ossification centre at the site of the stump, with remodelling of
the residual proximal phalanx of the first toe and (b) radiograph of the left foot of Case 3 showing new callous formation and
periosseous soft tissue swelling at the first metatarsal, with new erosions at the medial aspect and a periosteal reaction at the
lateral aspect.
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The reduction in symptoms as the lesion matures is in
contrast to potentially malignant lesions which tend
to get worse with time.5
Diagnosis
A diagnosis of Myositis ossificans is most frequently
made using a combination of clinical and radiological
findings. Depending on timing, a plain radiograph
may show nothing, a soft tissue density or an ossified
lesion.5 The early stages may also show a periosteal
reaction and bone marrow oedema. These can be
non-specific on Magnetic resonance imaging, but
the mineralisation is visible on CT with a non-ossified
centre early on, an osteoid shell and then mature
bone.9 Nevertheless, the role of Magnetic resonance
imaging in the diagnosis of early Myositis ossificans
without calcification or ossification is becoming
increasingly recognised.10 Where diagnostic uncer-
tainty remains, a tissue biopsy or excision may be
necessary.2,3 Biopsies that preserve the zonal struc-
ture will help provide a stronger basis for diagnosis,
whereas an aspiration is less likely to demonstrate
this. However, in people with diabetes related foot
disease this may not be possible. For example, in
our centre, bone biopsies are not performed routinely,
and after discussion with our radiologists, Magnetic
resonance imaging is the preferred imaging modality
of choice for diabetes related foot disease rather than
computed tomographic imaging. Biopsy would be
important if there were a suspicion of any of the
other differential diagnoses. These include periosteal
or extraosseous osteosarcoma, fibrous histiocytoma
or a synovial sarcoma. In our case series, we saw no
common pattern of muscle involvement.
Management
Myositis ossificans is a benign and self-limiting con-
dition that usually requires no active treatment if the
patient is asymptomatic.2 Myositis ossificans lesions
may resolve spontaneously. However, if the patient
experiences pain, discomfort or a limited range of
motion, previous authors have suggested a combin-
ation of initial treatment with rest, ice, compression
and elevation.5,11 If symptoms persist then surgical
resection has been suggested, but only after the
excess bone formation has stopped. This can be
picked up by isotope bone scanning.5,9 Even so, inva-
sive surgical resection may compromise local function
and lead to local relapse. Because of this, Myositis
ossificans has been referred to as a ‘don’t- touch
lesion’.12 This suggests that surgical intervention
should only be considered if function is impaired,
and once the lesion has fully matured.
Some literature exists on the medical prophylaxis
of Myositis ossificans. The role of non-steroidal anti-
inflammatory drugs in the prophylaxis of Myositis
ossificans following hip arthroplasty has been well
documented; however, no studies have investigated
the role of non steroidal anti-inflammatory drugs in
post-traumatic Myositis ossificans.13 Similarly,
bisphosphonates have also been found to be effective
in the prophylaxis of Myositis ossificans formation in
patients with spinal cord injuries. However, they have
not been shown to be effective once Myositis ossifi-
cans has developed.14
In someone with an ‘at risk’ foot, such as those with
diabetes, the excess bone can alter the biomechanics
and cause abnormal weight distribution through the
foot. Combined with peripheral neuropathy, the risks
of developing Charcot disease and diabetic foot disease
may warrant further surgical management. Although
the prevalence of Myositis ossificans in the diabetic
foot is not known, surgical intervention should be con-
sidered when the functional impact of altered biomech-
anics combined with the risk of developing Charcot
neuroarthropathy and ulceration outweighs the risks
associated with surgery.
In the cases described, all of the patients had dia-
betes related foot disease and twohadbeen treatedwith
antibiotics for presumed osteomyelitis. The antibiotics
failed to improve the symptoms and radiographic find-
ings. This discrepancy between the clinical and the
radiographic findings prompted a multidisciplinary
review of the cases, concluding that the bony lesions
identified were most likely Myositis ossificans.
There are some limitations to these reports that we
acknowledge. The radiological images that we have
presented are limited mainly to T1-weighted images,
and these show periosteal new bone and perhaps some
dystrophic bone. These could be described as hetero-
topic bone and, as mentioned, the terms myositis ossi-
ficans and heterotropic ossification are often used
interchangeably.5 In addition, because these cases
were collected over time; we are unable to go back
and obtain adequate T2-weighted fat saturated
images to show any inflammation that may be present.
Furthermore, while CT imaging may have been more
appropriate to detect osteomyelitis as the underlying
cause of the Myositis ossificans, more recent data sug-
gest that Magnetic resonance imaging is better for
making an early diagnosis of Myositis ossificans.15
We also acknowledge that bone biopsy may have
helped clarify the diagnosis, but this procedure is not
carried out by our specialist foot and ankle surgeons,
podiatrists or radiologists at our institution.
We suggest that these Myositis ossificans lesions
developed primarily as a result of trauma and/or sur-
gery (as in Case 1) or may have occurred concurrently
Sharma et al. 5
or as a result of osteomyelitis (Cases 1–3). To our
knowledge, there has only been one report of con-
comitant Myositis ossificans and osteomyelitis.16
Unlike our cases, where there was no evidence of
the Myositis ossificans prior to the patients becoming
symptomatic, Mishra et al. reported that their patient
had Myositis ossificans six months prior to develop-
ing osteomyelitis. We have been unable to find any
cases reporting Myositis ossificans occurring as a
result of osteomyelitis.
The importance of identifying Myositis ossificans
in the diabetes population is two-fold. Firstly, early
diagnosis may be confused with malignant conditions
such as osteosarcoma or infective conditions such as
osteomyelitis. Early identification would potentially
prevent unnecessary surgical intervention or pro-
longed courses of antibiotics. Second, the formation
of Myositis ossificans with diabetes related foot dis-
ease, combined with peripheral neuropathy, as previ-
ously highlighted, may predispose to the development
of Charcot neuroarthropathy. Furthermore, altered
biomechanics may precipitate the development of
pressure ulcers. We suggest that clinicians consider
a diagnosis of Myositis ossificans if clinical symptoms
do not correlate to radiological evidence of osteomye-
litis and/or the formation of heterotopic bone.
Summary and conclusion
We have presented three cases of Myositis ossificans
in the diabetic foot. It is important to consider the
potential impact of Myositis ossificans in patients
with diabetes mellitus because it can change the bio-
mechanics within the foot and potentially worsen
functional outcomes. The presented case series high-
lights the importance of early podiatric care, and the
influence of a multidisciplinary foot team, in patients
with long-term diabetes. Such an approach may help
avoid diabetic and orthopaedic foot complications in
such populations.
Because the prevalence of diabetes is increasing,
the absolute number of people with foot disease will
also increase. A proportion of those will require sur-
gery. Thus, we suggest that it is important for all
members of the multidisciplinary foot team to be
aware of Myositis ossificans as a possible complica-
tion of osteomyelitis or surgery in the diabetic foot.
Early identification may prevent unnecessary investi-
gations and interventions.
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